SecBot SecBot

MMEDS Act of 2023

H.R. 447 Rep. Jenniffer Gonzalez-Colon (R-PR) In committee
Bill text PDF
  1. Introduced Jan 24
  2. Committee Jan 24
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jan 24, 2023Next: House vote
1373d ago Jan 24, 2023: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 1 filing
Subscribe to see spend
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Energy 1
Search all 1 companies, their asks and price moves Subscribe

Summary

Medical Manufacturing, Economic Development, and Sustainability Act of 2023 or the MMEDS Act of 2023

Full summary1 paragraphs

This bill provides incentives for relocating medical manufacturing facilities in the United States and for manufacturing medical products (i.e., drugs and devices) in economically distressed zones. Specifically, the bill allows a income tax credit for 40% of the sum of wages paid in a medical manufacturing economically distressed zone, employee fringe benefit expenses, and depreciation and amortization allowances with respect to qualified medical manufacturing facility property, and a credit for economically distressed zone products and services acquired by domestic medical manufacturers. The bill increases the credit rate for minority businesses.

Library of Congress summary, Jan 24, 2023

Summary versions
  • Introduced in HouseJan 24, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.